Literature DB >> 8644703

Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.

S A Gayther1, P Harrington, P Russell, G Kharkevich, R F Garkavtseva, B A Ponder.   

Abstract

Germ-line mutations of the BRCA1 gene are responsible for a substantial proportion of families with multiple cases of early-onset breast and/or ovarian cancer. Since the isolation of BRCA1 last year, >65 distinct mutations scattered throughout the coding region have been detected, making analysis of the gene time consuming and technically challenging. We have developed a multiplex heteroduplex analysis that is designed to analyze one-quarter of the coding sequence in a single-step screening procedure and that will detect approximately 50% of all BRCA1 mutations so far reported in breast/ovarian cancer families. We have used this technique to analyze BRCA1 in 162 families with a history of breast and/or ovarian cancer and identified 12 distinct mutations in 35 families.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8644703      PMCID: PMC1914578     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

2.  Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli.

Authors:  S A Gayther; D Wells; S B SenGupta; P Chapman; K Neale; K Tsioupra; J D Delhanty
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

3.  Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.

Authors:  L S Friedman; E A Ostermeyer; C I Szabo; P Dowd; E D Lynch; S E Rowell; M C King
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

4.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.

Authors:  L H Castilla; F J Couch; M R Erdos; K F Hoskins; K Calzone; J E Garber; J Boyd; M B Lubin; M L Deshano; L C Brody
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

5.  Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.

Authors:  J Simard; P Tonin; F Durocher; K Morgan; J Rommens; S Gingras; C Samson; J F Leblanc; C Bélanger; F Dion
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

6.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Authors:  D Shattuck-Eidens; M McClure; J Simard; F Labrie; S Narod; F Couch; K Hoskins; B Weber; L Castilla; M Erdos
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

7.  Protein truncation test (PTT) for rapid detection of translation-terminating mutations.

Authors:  P A Roest; R G Roberts; S Sugino; G J van Ommen; J T den Dunnen
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

8.  Mutation analysis of the BRCA1 gene in ovarian cancers.

Authors:  H Takahashi; K Behbakht; P E McGovern; H C Chiu; F J Couch; B L Weber; L S Friedman; M C King; M Furusato; V A LiVolsi
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

9.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  Molecular diagnosis of familial adenomatous polyposis.

Authors:  S M Powell; G M Petersen; A J Krush; S Booker; J Jen; F M Giardiello; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  23 in total

1.  The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

Authors:  J F Stratton; D Thompson; L Bobrow; N Dalal; M Gore; D T Bishop; I Scott; G Evans; P Daly; D F Easton; B A Ponder
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Combined SSCP/duplex analysis by capillary electrophoresis for more efficient mutation detection.

Authors:  P Kozlowski; W J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

3.  Rapid detection of deletion, insertion, and substitution mutations via heteroduplex analysis using capillary- and microchip-based electrophoresis.

Authors:  H Tian; L C Brody; J P Landers
Journal:  Genome Res       Date:  2000-09       Impact factor: 9.043

4.  Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

Authors:  F Durocher; P Tonin; D Shattuck-Eidens; M Skolnick; S A Narod; J Simard
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

5.  BRCA1 mutation update and analysis.

Authors:  K Grade; B Jandrig; S Scherneck
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

Authors:  S J Ramus; Z Kote-Jarai; L S Friedman; M van der Looij; S A Gayther; B Csokay; B A Ponder; E Olah
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

7.  Population genetics of BRCA1 and BRCA2.

Authors:  C I Szabo; M C King
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

8.  Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

Authors:  S A Gayther; P Harrington; P Russell; G Kharkevich; R F Garkavtseva; B A Ponder
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

9.  MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.

Authors:  Fan Zhang; Gregory Bick; Jung-Young Park; Paul R Andreassen
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

10.  BRCA1 and BRCA2 mutations in Scotland and Northern Ireland.

Authors: 
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.